Gainers
- Addentax Group Corp. ATXG shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
- CymaBay Therapeutics, Inc. CBAY surged 40% to $10.97.
- Cyteir Therapeutics, Inc. CYT shares gained 38% to $2.6487. Cyteir Therapeutics reported discontinuation of CYT-0851 development program and planned liquidation and dissolution.
- TOP Financial Group Limited TOP shares gained 32.2% to $10.31 after the company reported FY23 financial results.
- Renalytix Plc RNLX shares jumped 31% to $2.66 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
- Baudax Bio, Inc. BXRX gained 24% to $0.6450 after the company agreed to acquire TeraImmune in a stock-for-stock transaction.
- Friedman Industries, Incorporated FRD rose 19.6% to $11.90 after posting a profit for the fourth quarter.
- CytomX Therapeutics, Inc. CTMX gained 17.7% to $1.65 after the company announced a $30 million private placement from BVF Partners L.P.
- Rackspace Technology, Inc. RXT gained 15.8% to $2.27. Rackspace Technology partnered with Google Cloud to offer cutting-edge generative AI services and solutions using the FAIR practice.
- Applied Optoelectronics, Inc. AAOI gained 15.5% to $6.27.
- MicroVision, Inc. MVIS climbed 12.8% to $4.40.
- XPeng Inc. XPEV gained 12.4% to $13.29 after CLSA upgraded the stock from Buy to Outperform and raised the price target from $10 to $13.1. The company, on Thursday. launched G6 Ultra Smart Coupe SUV in China.
- Alvotech ALVO rose 12.2% to $7.74. The FDA issued a complete response letter to second application for AVT02, biosimilar candidate for Humira.
- Digital Turbine, Inc. APPS gained 11.3% to $9.58.
- Eiger BioPharmaceuticals, Inc. EIGR climbed 11% to $0.6101. Baird maintained Eiger BioPharmaceuticals with an Outperform and raised the price target from $3 to $5.
- Aurinia Pharmaceuticals Inc. AUPH shares rose 9% to $9.98 after the board announced exploration of strategic alternatives to maximize shareholder value.
- IMAC Holdings, Inc. BACK rose 8.6% to $0.1195 after declining around 4% on Thursday.
- Accolade, Inc. ACCD gained 8.4% to $13.71 after the company reported better than expected first-quarter earnings.
- Carnival Corporation CCL climbed 7.8% to $18.50 after Jefferies upgraded the stock from Hold to Buy and raised the price target from $9 to $25.
- Better Choice Company Inc. BTTR shares gained 6.9% to $0.2310 after declining 6% on Thursday. Better Choice recently announced a $5 million investment from Alphia.
Losers
- iMedia Brands, Inc. IMBIL dipped 37% to $0.7686 after dropping over 70% on Thursday.
- Unicycive Therapeutics, Inc. UNCY fell 23.4% to $1.26 after the company provided an update concerning its marketing application for lanthanum dioxycarbonate for hyperphosphatemia in chronic kidney disease patients on dialysis.
- Apyx Medical Corporation APYX fell 20.4% to $5.32. Apyx® Medical is expected to report financial results for the second quarter on Thursday, Aug. 10.
- Evelo Biosciences, Inc. EVLO dropped 19.5% to $2.84. Evelo Biosciences announced a 1-for-20 reverse stock split.
- Paltalk, Inc. PALT shares dipped 18.8% to $2.29.
- Cineverse Corp. CNVS fell 17.8% to $1.89 after the company reported weak fourth-quarter sales.
- Surgalign Holdings, Inc. SRGA dipped 17.6% to $0.2249.
- Fangdd Network Group Ltd. DUO shares dropped 16.2% to $0.8466 after jumping 31% on Thursday.
- Kintara Therapeutics, Inc. KTRA dipped 16.2% to $3.53. Kintara Therapeutics secured $2 million National Institutes Of Health SBIR grant to support development of REM-001.
- Kiromic BioPharma, Inc. KRBP fell 14.1% to $2.74. Kiromic Biopharma recently appointed Brian Hungerford as interim CFO.
- Advanced Health Intelligence Ltd. AHI dropped 12.5% to $4.34. Advanced Health Intelligence announced implementation of ADS ratio change with effect of 1:4 reverse ADS split.
- Root, Inc. ROOT fell 12% to $9.87. Root said it is not in receipt of any proposal that is either actionable or in the best interests of shareholders.
- Foghorn Therapeutics Inc. FHTX declined 11.2% to $7.27.
- TuSimple Holdings Inc. TSP fell 10.4% to $1.6480.
- Eos Energy Enterprises, Inc. EOSE dropped 10.3% to $4.42 after B. Riley Securities downgraded the stock from Buy to Neutral.
- P3 Health Partners Inc. PIII fell 9.5% to $2.96. TD Cowen initiated coverage on P3 Health Partners with a Market Perform rating.
- Novonix Limited NVX dropped 8.1% to $2.50.
- Hillstream BioPharma, Inc. HILS declined 7.7% to $0.36.
- Golden Sun Education Group Limited GSUN shares dropped 7.6% to $1.0350.
- 1-800-FLOWERS.COM, Inc. FLWS dropped 6.5% to $7.77. 1-800-FLOWERS.COM said CEO Christopher Mccann Will be stepping down for personal health reasons, effective July 3, 2023.
- Ontrak, Inc. OTRK shares fell 6% to $0.4716 after the company filed for secondary stock offering together with warrants.
Now Read This: Bitcoin Tops $31,000; eCash, Bitcoin Cash Among Top Gainers
ACCDAccolade Inc
$6.87-0.29%
ALVOAlvotech
$13.360.68%
APPSDigital Turbine Inc
$2.168.00%
APYXApyx Medical Corp
$1.400.72%
ATXGAddentax Group Corp
$0.70990.70%
AUPHAurinia Pharmaceuticals Inc
$7.74-3.37%
BACKIMAC Holdings Inc
$1.25-5.30%
BTTRBetter Choice Co Inc
$2.171.88%
BXRXBaudax Bio Inc Ordinary Shares
$0.0218-%
CCLCarnival Corp
$25.72-0.50%
CNVSCineverse Corp
$3.42-3.39%
CTMXCytomX Therapeutics Inc
$0.87804.52%
DUOFangdd Network Group Ltd
$0.6060-0.66%
EOSEEos Energy Enterprises Inc
$5.73-4.82%
EVLOEvelo Biosciences Inc
$0.00050-%
FHTXFoghorn Therapeutics Inc
$4.412.32%
FLWS1-800-Flowers.com Inc
$8.372.83%
FRDFriedman Industries Inc
$13.80-1.08%
GSUNGolden Sun Health Technology Group Ltd
$2.80-6.04%
KRBPKiromic BioPharma Inc
$0.92105.86%
MVISMicrovision Inc
$1.5910.4%
NVXNOVONIX Ltd
$1.57-11.8%
OTRKOntrak Inc
$1.802.85%
PIIIP3 Health Partners Inc
$0.1950-5.34%
ROOTRoot Inc
$81.00-5.05%
RXTRackspace Technology Inc
$2.501.21%
TOPTOP Financial Group Ltd
$1.45-1.36%
UNCYUnicycive Therapeutics Inc
$0.65285.29%
XPEVXPeng Inc
$14.996.09%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in